Dianthus Therapeutics, Inc. DNTH
82.70 USD +0.45 (+0.55%)
At closeNov 3, 2026, 4:00 PM EST
82.70 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
81.91 Day range 86.17
33.20 52-week range 115.96
- YTD
- +100.68%
- 1 year
- +143.02%
Held by funds
136 US ETFs and mutual funds hold DNTH · largest positions
Ownership
Held by insiders 0.12%
Held by institutions 129.95%
Float held by institutions 130.11%
Institutions 374
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.96% | 8,199,893 | 678.13M | Jun 29, 2026 |
| Blackrock Inc. | 7.53% | 4,123,822 | 341.04M | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 7.10% | 3,888,456 | 321.58M | Jun 29, 2026 |
| Wellington Management Group, LLP | 5.89% | 3,229,882 | 267.11M | Jun 29, 2026 |
| Fairmount Funds Management LLC | 4.63% | 2,537,191 | 209.83M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 4.59% | 2,514,946 | 207.99M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.01% | 1,649,920 | 136.45M | Jun 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.91% | 1,592,149 | 131.67M | Aug 30, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 2.74% | 1,503,955 | 124.38M | Jul 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.52% | 1,380,523 | 114.17M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.23% | 1,224,305 | 101.25M | Sep 29, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 2.11% | 1,155,511 | 95.56M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CARR EDWARD | Officer | Sale | Mar 11, 2026 | 0 |
| GARCIA MARINO | Chief Executive Officer | Sale | Aug 6, 2026 | 65,292 |
| MCGEORGE ANNE | Director | Sale | Aug 9, 2026 | 0 |
| RANDHAWA SIMRAT | Officer | Sale | Aug 31, 2026 | 4,000 |
| READ SIMON J. | Director | Sale | Aug 18, 2026 | 0 |
| SAVITZ RYAN | Chief Financial Officer | Sale | Jul 8, 2026 | 0 |
